CAP Comments on CMS Antifraud Efforts, Urges Reevaluation of MolDX Program
The College of American Pathologists (CAP) submitted comments in response to a request for information on the Centers for Medicare & Medicaid...
TELCOR has identified ongoing processing challenges with BCBS New Jersey that laboratories should be aware of. When claims require medical records, BCBSNJ frequently does not take action on submitted documentation unless there is direct payer engagement. In our experience, speaking with a representative to match the claim to the medical records and maintaining consistent follow-up is often necessary before any processing occurs.
We also see BCBSNJ issue Denial Code 109 more frequently. While Blue Cross payers typically follow consistent jurisdiction rules configured within TELCOR RCM for efficient claim routing, BCBSNJ appears to apply jurisdiction requirements differently than other BCBS plans. As a result, a 109 denial often signals a jurisdiction mismatch rather than a true eligibility or coverage issue.
We recommend proactive follow-up and careful jurisdiction review when managing BCBSNJ claims to avoid unnecessary delays and denials.
- Sarah Stewart, Vice President, RCS
The College of American Pathologists (CAP) submitted comments in response to a request for information on the Centers for Medicare & Medicaid...
Lincoln, NE — April 1, 2026 — TELCOR Inc, a leading provider of healthcare technology solutions for laboratories and healthcare facilities, today...
The Centers for Medicare & Medicaid Services (CMS) issued a final rule on national standards for electronic claims attachments and signatures,...